Cell Lines & Specialty Cell Culture
- Сортировать:
- Вид таблицей
-
STBCi300-A 66541126-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender N/A growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi301-A 66541127-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender N/A growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi302-A 66541128-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender N/A growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi303-A 66541129-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi304-A 66541130-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi307-A 66541133-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi308-A 66541134-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi309-A 66541135-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi310-A 66541136-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Parkinsons disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi311-A 66541137-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender N/A growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) migraine disorder shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi312-A 66541138-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi313-A 66541139-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
STBCi314-A 66541140-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
StemBANCCCell Line DescriptionDerivation
Primary cell type: Erythroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: Unknown
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: -
HIV 2: -
Hepatitis B: -
Hepatitis C: -
Mycoplasma: Negative
Genotyping
Karyotyping
Cell line karyotype: No abnormalities detected
Karyotyping method: Molecular karyotyping by SNP arrayLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human erythroblast reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UCLi001-A 66540028-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: POU5F1 (OCT-4)(+) TRA 1-60 (+)SSEA-1(-)SSEA-4 (+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:BTUBULIN(-)FOXG1(+)HES5(+)NEUROD1(+)PAX6(+)Sox1 (+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)FOXA2(+)GATA6(+)GSC(+)SOX17(+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed: BMP4(+)DECORIN(+)GATA4(+)HAND1(+)PDGFRA(+)PECAM1(+)PITX1(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: -
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 48
Cell line karyotype: 46, XY
Karyotyping method: G-Banding
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (50-54) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) frontotemporal dementia shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UCLi002-A 66540029-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60(+)POU5F1 (OCT-4)(+)SSEA-4(+) SSEA-1(-)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:BUTUBULIN(+)FOXG1(-)HES5(+)NEUROD1(+)PAX6(+)Sox1(+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)FOXA2 (+)GATA6(+)GSC(-)SOX17(+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed: BMP4(+)DECORIN(+)GATA4(+)HAND1(+)PDGFRA(+)PECAM1(+)PITX1(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: -
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 49
Cell line karyotype: 46, XY
Karyotyping method: G-Banding
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (55-59) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) frontotemporal dementia shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UCLi003-A 66540027-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: SSEA-4(+) TRA 1-60(+)POU5F1 (OCT-4)(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:BTUBULIN(+)FOXG1(+)HES5(+)NEUROD1 (+)PAX6(+)Sox1(+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)FOXA2(+)GATA6(+)GSC(+)SOX17(+)
Mesoderm: In vitro spontaneous differentiation
MarkerExpressed:BMP4(+)DECORIN(+)GATA4(+)HAND1(+)PDGFRA(+)PECAM1(+)PITX1(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: -
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Cell line karyotype: 46, XX
Karyotyping method: G-Banding
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (N/A) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) frontotemporal dementia shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UCLi004-A 66540123-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: Unknown
Other:From the same donor: UCLi004-B, UCLi004-C
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60(+),POU5F1 (OCT-4)(+),SSEA-1 (-),SSEA-4 (+)
Differentiation potency
Ectoderm: HES5 (+)NeuroD1(+)PAX6 (+),Endoderm: CXCR4 (+)GATA6 (+)Sox17 (+),Mesoderm: DCN (+)MIXL1 (+)NCAM (+)PECAM(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 17
Cell line karyotype: 46,XY
Karyotyping method: G-Banding
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA)
- Cell Line Information Pack (CLIP)
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) amyotrophic lateral sclerosis (ALS) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point(F) Not applicable Flash Point(C) Not applicable Узнать цену -
UCLi004-B 66540154-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: Unknown
Other:From the same donor: UCLi004-A, UCLi004-C
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60(+)SSEA-4 (+)POU5F1 (OCT-4)(+)SSEA-1(-)
Differentiation potency:Ectoderm: HES5(+)NEUROD1(+)PAX6 (+),Endoderm: CXCR4 (+)GATA6 (+)SOX17 (+),Mesoderm: DCN (+)MLX1(+)VIMENTIN (+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 19
Cell line karyotype: 46,XY
Karyotyping method: G-Banding
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 20%
CO2 concentration: 5%
Culture medium: Essential E8®Legal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) amyotrophic lateral sclerosis (ALS) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UCLi004-C 66540165-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
University College LondonCell Line DescriptionDerivation
Primary cell type: Fibroblast
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: Unknown
Other:From the same donor: UCLi004-A, UCLi004-B
Characterization
Marker expression: TRA 1-60(+)SSEA-1(-)SSEA-4(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Endoderm: In vitro spontaneous differentiation
Mesoderm: In vitro spontaneous differentiation
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 22
Cell line karyotype: No autosomal or sex chromosome aneuplodies detected
Karyotyping method: Karyolite BoBs
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) amyotrophic lateral sclerosis (ALS) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi001-B 66540043-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: Sept. 25, 2008
Passage number reprogrammed: p4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Absence of reprogramming vector(s): yes
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: POU5F1 (OCT-4)(+)TRA 1-60(+)TRA 1-81(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell,In vivo teratoma,In vitro directed differentiation
Endoderm: In vivo teratoma,In vitro directed differentiation
Mesoderm: In vivo teratoma,In vitro directed differentiation
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 13
Cell line karyotype: 46xy
Karyotyping method: SNP-karyotyping
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (40-44) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) spinocerebellar ataxia (Type 3) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi002-A 66540005-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: Sept. 25, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-81(+)POU5F1 (OCT-4)(+)TRA 1-60 (+)SSEA-3(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell
In vivo teratoma
In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (65-69) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi003-A 66540007-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: June 19, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: POU5F1 (OCT-4)(+)TRA 1-60(+)SSEA-3(+)TRA 1-81(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell,In vivo teratoma,In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (35-39) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) spinocerebellar ataxia (Type 4) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi004-A 66540009-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: June 19, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60(+)SSEA-3(+)POU5F1 (OCT-4)(+)TRA 1-81(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell
In vivo teratoma
In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1
Passage Number banked (pre-EBiSC): P30
No. Vials banked (pre-EBiSC): 30Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (30-34) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi005-A 66540008-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: Aug. 26, 2009
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-81(+)SSEA-3(+)TRA 1-60(+)POU5F1 (OCT-4)(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell
In vivo teratoma
In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi006-A 66540004-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: Feb. 4, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-81(+)TRA 1-60 (+)SSEA-3(+)POU5F1 (OCT-4)(+)
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell
In vivo teratoma
In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (30-34) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi007-A 66540011-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bonn, Germany
Tissue collection date: Oct. 27, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60(+)SSEA-3(+)POU5F1 (OCT-4)(+)TRA 1-81(+)
hPSC Scorecard: Self-renewal,Endoderm,Mesoderm,Ectoderm
Differentiation potency
Ectoderm: Neuroepithelial Stem Cell,In vivo teratoma,In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 5%
Culture medium: mTeSR® 1
Passage Number banked (pre-EBiSC): P11
No. Vials banked (pre-EBiSC): 30Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (40-44) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) spinocerebellar ataxia (Type 5) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi008-A 66540003-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Germany
Tissue collection date: Nov. 6, 2008
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression: SSEA-3(+)POU5F1 (OCT-4)(+)TRA 1-81(+)TRA 1-60(+)
Differentiation potency
Ectoderm:Neuroepithelial Stem Cell,In vivo teratoma,In vitro directed differentiation
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: -
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: mTeSR®
Passage method: EDTA
Matrix: Matrigel® / Geltrex®
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
mTeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human dermis (fibroblast) reprogramming method retrovirus description age (40-44) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) spinocerebellar ataxia (Type 6) shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi011-A 66540594-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Universitatsklinikum BonnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr
Files showing reprogramming vector expressed or silenced: Image / Result
Vector map: File
Vector Free Reprogramming
Types of factor(s) used: mRNA
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
TRA 1-60 Yes -
TRA 1-81 Yes -
hPSC Scorecard
Positive Negative
Self-renewal
Endoderm
Mesoderm
Ectoderm
Data analysis report: scorecard_mv.png
Morphology:
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Passage number: 31
Cell line karyotype: normal
Karyotyping method: Molecular karyotyping by SNP array
Image / ResultLinkage- EBiSC Access Use Agreement (EAUA)
- Cell Line Information Pack (CLIP)
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 21%
CO2 concentration: 6%
Culture medium: other
Culture base medium: StemMACS™ iPS-Brew XF
Main protein source: -
Passage Number banked (pre-EBiSC): 31
No. Vials banked (pre-EBiSC): 30Legal InformationEBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
StemMACS is a trademark of Miltenyi Biotec GmbHПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (80-84) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point(F) Not applicable Flash Point(C) Not applicable Узнать цену -
UKBi011-A-1 66540617-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
BioneerCell Line DescriptionDerivation
Primary cell type: -
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: No
Notes on reprogramming vector detection: refer to UKBi011-A
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Passage number: 28
Cell line karyotype: 46 XY
Image / Result
Genetic Modification
Disease/phenotype related modifications
Disease: Alzheimers disease
Type of modification: Gene knock-out
Chromosome location: 19q13.32
Delivery method: CRISPR-associated (CRISPR/Cas) System
Description: insertion of a stop codon and a frame shift into exon 1Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 18%
CO2 concentration: 5%
Culture medium: TeSR® E8®
Passage Number banked (pre-EBiSC): 32
No. Vials banked (pre-EBiSC): 20Legal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.
TeSR is a registered trademark of WiCell Research Institute, Inc.Параметрыbiological source human reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKBi011-A-4 66540620-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
BioneerCell Line DescriptionDerivation
Primary cell type: -
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Is the reprogramming vector detectable: No
Notes on reprogramming vector detection: refer to BIONi011-A
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Passage number: 28
Cell line karyotype: 46, XY
Image / Result
Genetic Modification
Disease/phenotype related modifications
Disease: Alzheimers disease
Type of modification: Isogenic
Chromosome location: 19q13.32
Nucleotide sequence HGSV: rs429358 (C/T); rs7412 (C/C)
Protein sequence HGSV: 112Cys/112Arg, 158Arg/158Arg
Zygosity: Heterozygous
Target locus modification: APOE 3/4 genotypeLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Matrigel®/Geltrex®
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 18%
CO2 concentration: 5%
Culture medium: Essential E8®
Passage Number banked (pre-EBiSC): 27
No. Vials banked (pre-EBiSC): 30Legal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-Gesellschaft
GELTREX is a registered trademark of Life Technologies Corporation
Matrigel is a registered trademark of Corning, Inc.Параметрыbiological source human reprogramming method Sendai virus description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) Alzheimers disease shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi006-A 66540018-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Mesenchymal stem cell of the bone marrow
Primary cell developmental stage: Adult
Location of primary tissue procurement: Aachen, Germany
Tissue collection date: April 21, 2010
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Yes
Merthods used: rtpcr
Notes on reprogramming vector silencing: Retrovirally encoded reprogramming factors OSKM are not expressed in iPSCs as determined by RT-PCR
Files showing reprogramming vector expressed or silenced: Image / Result
Vector map: File
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA1-80(+)ZFP42 (REX-1)(+)TRA 1-60 (+) SSEA-4(+)TRA 1-80(+)NANOG(+)POU5F1 (OCT-4)(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Cell line karyotype: Deletion of the short arm and duplikation of the long arm of Chr20 were detected.
Karyotyping method: Molecular karyotyping by SNP array
Genotyping
Genome-wide analysis:
Methylation profiling
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human bone-marrow-derived MSC reprogramming method retrovirus description age (60-64) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi007-A 66540001-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Berlin, Germany
Tissue collection date: June 15, 2009
Passage number reprogrammed: P3
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Have the reprogramming vectors been silenced: Yes
Merthods used: rtpcr
Notes on reprogramming vector silencing: Retrovirally encoded reprogramming factors OCT4, KLF4 and cMYC are not expressed as determined by RT-PCR. Only Sox2 seems to be expressed. at very low levels.
Files showing reprogramming vector expressed or silenced: Image / Result
Vector map: File
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-80(+)SSEA-4 (+)POU5F1 (OCT-4) (+)Alkaline Phosphatase(+)NANOG(+)
Differentiation potency
Ectoderm: In vivo teratoma
Endoderm: In vivo teratoma
Mesoderm: In vivo teratoma
In vitro spontaneous differentiation
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 34
Cell line karyotype: 46, XX
Karyotyping method: Molecular karyotyping by SNP array
Genotyping
Genome-wide analysis:
SNP genotyping using OmniExpress Exome Chip
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (45-49) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) ventricular tachycardia shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi007-B 66540013-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Berlin, Germany
Tissue collection date: June 15, 2009
Passage number reprogrammed: P3
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Unknown
Vector map: File
Other:From the same donor: UKKi007-A
Characterization
Analysis of Undifferentiated Cells
Marker expression: POU5F1 (OCT-4)(+)TRA1-80(+)SSEA-4(+)NANOG(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:B-TUBULIN(+)FOXG1(-)HES5(+)NEUROD1(+)PAX6 (+)Sox1(+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:BMP4(+)DCN(+)GATA4(-)HAND1(+)PDGF(+)PECAM (+)VIMENTIN(+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed:ACTN2, cardiac alpha actinin(+)CXCR4(+)FOXA2(-)GATA6 (+)GSC (+)MLC2v, myosin light chain 2v (+)MYH6, alpha myosin heavy chain(+)PITX1 (+)RYR2 (+)SOX17(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Karyotyping method: Molecular karyotyping using using OmniExpress Exome Chip
Genotyping
Genome-wide analysis:
SNP-genotyping using OmniExpress Exome Chip
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method retrovirus description age (45-49) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) ventricular tachycardia shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi008-A 66540015-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bad Oeynhausen, Germany
Tissue collection date: Aug. 5, 2009
Passage number reprogrammed: P3
Reprogramming method
Vector type: Integrating
Vector: Transposon
Transposon: Sleeping beauty
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the used vector excisable?: yes
Absence of reprogramming vector(s): yes
Have the reprogramming vectors been silenced: Yes
Merthods used: pcr
Files showing reprogramming vector expressed or silenced: Image / Result
Vector Free Reprogramming
Types of factor(s) used: miRNA
Characterization
Analysis of Undifferentiated Cells
Marker expression: NANOG(+)POU5F1 (OCT-4)(+)SSEA-4(+)TRA 1-80(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:B-TUBULIN(-)FOXG1(+)HES5(+)NEUROD1(+)PAX6(+)Sox1(+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)FOXA2(-)GATA6 (-)GSC(+)PITX1(+)SOX17 (-)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed:BMP4 (+)DCN(+)GATA4(+)HAND1(+)PDGF(-)PECAM(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: P21
Cell line karyotype: Normal male chromosome complement and banding pattern.
Karyotyping method: G-Banding
Genotyping
Genome-wide analysis:
Molecular karyotyping using OmniExpress Exome Chip
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method transposon description age (30-34) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) prolonged QT interval shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi009-A 66540002-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bad Oeynhausen, Germany
Tissue collection date: June 2, 2009
Passage number reprogrammed: P3
Reprogramming method
Vector type: Integrating
Vector: Transposon
Transposon: Sleeping beauty
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the used vector excisable?: yes
Absence of reprogramming vector(s): yes
Have the reprogramming vectors been silenced: Yes
Merthods used: pcr
Files showing reprogramming vector expressed or silenced: Image / Result
Other:From the same donor: UKKi009-B
Characterization
Analysis of Undifferentiated Cells
Marker expression: NANOG(+)TRA 1-80(+)SSEA-4 (+)POU5F1 (OCT-4)(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:B-TUBULIN (-)FOXG1(+)HES5(+)NEUROD1(+)PAX6(+)Sox1(+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)+L350FOXA2(-)GATA6(+)GSC(+)PITX1(+)SOX17(+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed:BMP4(+)DCN(+)GATA4(-)HAND1(+)PDGF(-)PECAM(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 30
Cell line karyotype: 46XX
Karyotyping method: Molecular SNP karyotyping using OmniExpress Exome Chip
Genotyping
Genome-wide analysis (donor):
HumanOmniExpressExome-8 BeadChip v1.2 (Illumina, Inc.)
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method transposon description age (35-39) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) prolonged QT interval shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi009-B 66540032-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Bad Oeynhausen, Germany
Tissue collection date: June 2, 2009
Passage number reprogrammed: P3
Reprogramming method
Vector type: Integrating
Vector: Transposon
Transposon: Sleeping beauty
Is the used vector excisable?: yes
Absence of reprogramming vector(s): yes
Have the reprogramming vectors been silenced: Yes
Merthods used: pcr
Files showing reprogramming vector expressed or silenced: Image / Result
Other:From the same donor: UKKi009-A
Characterization
Analysis of Undifferentiated Cells
Marker expression: TRA 1-60 (+)TRA 1-80(+) SSEA-4 (+)POU5F1 (OCT-4)(+) NANOG(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:B-TUBULIN(-)FOXG1(+)HES5(+)NEUROD1(+)PAX6(+)Sox1 (+)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4 (+)FOXA2(-)GATA6(+)GSC(+)PITX1 (+)SOX17(+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed:BMP4(+)DCN(+)GATA4(+)HAND1(+)PDGF(-)PECAM(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 31
Cell line karyotype: 46,XX
Karyotyping method: SNP-genotyping using HumanOmniExpressExome-8 BeadChip v1.2 (Illumina)
Genotyping
Genome-wide analysis (donor):
HumanOmniExpressExome-8 BeadChip v1.2 (Illumina, Inc.)
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method transposon description age (35-39) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) prolonged QT interval shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi011-A 66540010-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Fibroblast of dermis
Primary cell developmental stage: Adult
Location of primary tissue procurement: Geneva, Switzerland
Tissue collection date: March 6, 2013
Passage number reprogrammed: P4
Reprogramming method
Vector type: Non-integrating
Vector: Episomal
Gene list:
KLF4
L-Myc
POU5F1
sh-p53
SOX2
Is the reprogramming vector detectable: Unknown
Characterization
Analysis of Undifferentiated Cells
Marker expression:Alkaline Phosphatase(+)SSEA-3(+)TRA 1-60(+)SSEA-4(+)POU5F1 (OCT-4)(+)TRA 1-80(+)NANOG(+)
Differentiation potency
Ectoderm: In vitro spontaneous differentiation
Marker Expressed:B-TUBULIN(-)HES5(+)NEUROD1(+)PAX6(-)PDGF(+)Sox1(-)
Endoderm: In vitro spontaneous differentiation
Marker Expressed:CXCR4(+)FOXA2(-)GATA6 (+)GSC(-)PITX1(+)SOX17 (+)
Mesoderm: In vitro spontaneous differentiation
Marker Expressed:BMP4(+)DCN(+)HAND1(+)PDGF(+)PECAM(+)VIMENTIN(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 35
Cell line karyotype: 46,XY
Karyotyping method: Molecular karyotyping using OmniExpress Exome Chip
Genotyping
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) Quality Level 100, reprogramming method episomal description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi012-A 66540019-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.
Cell Line Origin
Depositor
Klinikum der Universitat zu Koln
Cell Line Description
Derivation
Primary cell type: Mesenchymal stem cell of the bone marrow
Primary cell developmental stage: Adult
Location of primary tissue procurement: Aachen, Germany
Tissue collection date: April 21, 2010
Passage number reprogrammed: P4
Reprogramming method
Vector type: Integrating
Vector: Virus
Virus type: Retrovirus
Gene list:
KLF4
MYC
POU5F1
SOX2
Have the reprogramming vectors been silenced: Yes
Merthods used: rtpcr
Notes on reprogramming vector silencing: Retrovirally encoded reprogramming factors OSKM are not expressed in iPSCs as determined by RT-PCR
Files showing reprogramming vector expressed or silenced: Image / Result
Vector map: File
Characterization
Analysis of Undifferentiated Cells
Marker expression: SSEA-4(+)ZFP42 (TRA1-80(+)TRA 1-80(+)POU5F1 (OCT-4)(+)NANOG(+)
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Not done
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Cell line karyotype: Deletion of the short arm and duplikation of the long arm of Chr20 were detected.
Karyotyping method: Molecular karyotyping by SNP array
Genotyping
Genome-wide analysis:
Methylation profiling
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- Additional Cell Line Info,
- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillment
Subculture Routine
Medium: Essential E8®
Passage method: EDTA
Matrix: Vitronectin
CO2 concentration: 5%
O2 concentration: 21%
Temperature: 37°CLegal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human dermis (fibroblast) reprogramming method episomal description age (N/A) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi017-A 66540475-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
TRA 1-80 Yes - -
SSEA-4 Yes - -
FOXD3 Yes -
CD90 Yes -
DNMT3b Yes -
NANOG Yes - -
OCT 4 Yes - -
SSEA-1 Yes -
SOX2 Yes -
Morphology:
morphology pictures of iPS cell line NP0075-8D before banking and of the thawing control
morphology pictures of iPS cell line NP0075-8D before banking and of the thawing control
morphology pictures of iPS cell line NP0075-8D before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0075-8D
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0075-8D
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0075-8D
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 36
Cell line karyotype: 46, XX
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
Genome-wide analysis:
SNP typing array
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) hypertrophic cardiomyopathy shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi017-B 66540476-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
DNMT3b Yes -
CD90 Yes -
FOXD3 Yes -
NANOG Yes - -
TRA 1-80 Yes - -
SSEA-4 Yes - -
SSEA-1 Yes -
SOX2 Yes -
OCT 4 Yes - -
Morphology:
morphology pictures of iPS cell line NP0075-10K before banking and of the thawing control
morphology pictures of iPS cell line NP0075-10K before banking and of the thawing control
morphology pictures of iPS cell line NP0075-10K before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0075-10K
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0075-10K
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0075-10K
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 39
Cell line karyotype: No larger chromosomal aberrations observed
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) hypertrophic cardiomyopathy shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi017-C 66540477-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
FOXD3 Yes -
OCT 4 Yes - -
SOX2 Yes -
NANOG Yes - -
SSEA-1 Yes -
DNMT3b Yes -
CD90 Yes -
SSEA-4 Yes - -
TRA 1-80 Yes - -
Morphology:
morphology pictures of iPS cell line NP0075-11B before banking and of the thawing control
morphology pictures of iPS cell line NP0075-11B before banking and of the thawing control
morphology pictures of iPS cell line NP0075-11B before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0075-11B
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0075-11B
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0075-11B
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 34
Cell line karyotype: No larger chromosomal aberrations observed
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (50-54) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) hypertrophic cardiomyopathy shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi018-A 66540478-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Primary cell line vendor: University Hospital Munster, Germany
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
NANOG Yes - -
SOX2 Yes -
TRA 1-80 Yes - -
SSEA-1 Yes -
OCT 4 Yes - -
SSEA-4 Yes - -
FOXD3 Yes -
CD90 Yes -
DNMT3b Yes -
Morphology:
morphology pictures of iPS cell line NP0080-2B before banking and of the thawing control
morphology pictures of iPS cell line NP0080-2B before banking and of the thawing control
morphology pictures of iPS cell line NP0080-2B before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0080-2B
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0080-2B
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0080-2B
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 33
Cell line karyotype: No larger chromosomal aberrations observed
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi018-B 66540479-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Primary cell line vendor: University Hospital Munster, Germany
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
CD90 Yes -
DNMT3b Yes -
OCT 4 Yes - -
SSEA-1 Yes -
SSEA-4 Yes - -
NANOG Yes - -
TRA 1-80 Yes - -
SOX2 Yes -
FOXD3 Yes -
Morphology:
morphology pictures of iPS cell line NP0080-6A before banking and of the thawing control
morphology pictures of iPS cell line NP0080-6A before banking and of the thawing control
morphology pictures of iPS cell line NP0080-6A before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0080-6A
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0080-6A
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0080-6A
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 34
Cell line karyotype: No larger chromosomal aberrations observed
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
Genome-wide analysis:
SNP typing array
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi018-C 66540569-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Primary cell line vendor: University Hospital Munster, Germany
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
SOX2 Yes -
TRA 1-80 Yes - -
SSEA-4 Yes - -
SSEA-1 Yes -
FOXD3 Yes -
DNMT3b Yes -
OCT 4 Yes - -
CD90 Yes -
NANOG Yes - -
Morphology:
morphology of iPS cell line NP0080-8B before banking and of the thawing control
morphology of iPS cell line NP0080-8B before banking and of the thawing control
morphology of iPS cell line NP0080-8B before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0080-8B
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0080-8B
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0080-8B
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 32
Cell line karyotype: No larger chromosomal aberrations observed
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi019-A 66540480-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
NANOG Yes - -
SSEA-1 Yes -
DNMT3b Yes -
FOXD3 Yes -
CD90 Yes -
SSEA-4 Yes - -
TRA 1-80 Yes - -
OCT 4 Yes - -
SOX2 Yes -
Morphology:
morphology pictures of NP0081-1A before banking and of the thawing control
morphology pictures of NP0081-1A before banking and of the thawing control
morphology pictures of NP0081-1A before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN differentiated iPS cell line NP0081-1A
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 differentiated iPS cell line NP0081-1A
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY differentiated iPS cell line NP0081-1A
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 34
Cell line karyotype: No larger chromosomal aberrations to be reported
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi019-B 66540481-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
DNMT3b Yes -
SOX2 Yes -
OCT 4 Yes - -
FOXD3 Yes -
NANOG Yes - -
SSEA-1 Yes -
TRA 1-80 Yes - -
SSEA-4 Yes - -
CD90 Yes -
Morphology:
morphology pictures of NP0081-11 before banking and of the thawing control
morphology pictures of NP0081-11 before banking and of the thawing control
morphology pictures of NP0081-11 before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0081-11
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0081-11
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0081-11
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 38
Cell line karyotype: No larger chromosomal aberrations to be reported
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi019-C 66540482-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: immune_staining, pcr
Notes on reprogramming vector detection: sendai virus absent
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
OCT 4 Yes - -
SSEA-1 Yes -
NANOG Yes - -
SSEA-4 Yes - -
SOX2 Yes -
TRA 1-80 Yes - -
CD90 Yes -
DNMT3b Yes -
FOXD3 Yes -
Morphology:
morphology pictures of NP0081-12C p35 before banking and of the thawing control
morphology pictures of NP0081-12C p35 before banking and of the thawing control
morphology pictures of NP0081-12C before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0081-12C
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0081-12C
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0081-12C
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Sterility
Inoculation for microbiological growth: No Contaminants Detected
Mycoplasma: Not Detected
Viability: Viable post-cryopreservation
Genotyping
Karyotyping
Passage number: 32
Cell line karyotype: No larger chromosomal aberrations to be reported
Karyotyping method: Molecular karyotyping by SNP array
Image / Result
STR/Fingerprinting: A 16 allele profile has been recorded and data is available upon request, after cell line purchase.Linkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineMedium: -
Passage method: -
Matrix: -
CO2 concentration: -
O2 concentration: -
Temperature: -Legal InformationEBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method Sendai virus description age (20-24) Торговая марка EBiSC™ gender female growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) familial long QT syndrome shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену -
UKKi020-A 66540483-1VL
General descriptionInduced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.Cell Line OriginDepositor
Klinikum der Universitat zu KolnCell Line DescriptionDerivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Passage number reprogrammed: 0
Reprogramming method
Vector type: Non-integrating
Vector: Episomal
Is the reprogramming vector detectable: No
Merthods used: pcr
Notes on reprogramming vector detection: episomal vector cassette absence
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
SOX2 Yes -
TRA 1-80 Yes - -
NANOG Yes - -
OCT 4 Yes - -
SSEA-4 Yes - -
FOXD3 Yes -
DNMT3b Yes -
Morphology:
morphology pictures of iPS cell line NP0100-4 before banking and of the thawing control
morphology pictures of iPS cell line NP0100-4 before banking and of the thawing control
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
expression of NESTIN in differentiated iPS cell line NP0100-4
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
expression of SOX17 in differentiated iPS cell line NP0100-4
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
expression of BRACHYURY in differentiated iPS cell line NP0100-4
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Passage number: 36
Cell line karyotype: Chr.01: Onset of a trisomy (25%)
Karyotyping method: Molecular karyotyping by SNP array
Image / ResultLinkage- EBiSC Access Use Agreement (EAUA),
- Cell Line Information Pack (CLIP),
Note: EAUA and CLIP must be completed before order fulfillmentSubculture RoutineSurface coating: Vitronectin
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 20%
CO2 concentration: 5%
Culture medium: Essential E8®
Passage Number banked (pre-EBiSC): 34
No. Vials banked (pre-EBiSC): 20Legal InformationE8 is a registered trademark of WIsconsin Alumni Research Foundation non-stock Corporation
EBiSC is a trademark of Fraunhofer-GesellschaftПараметрыbiological source human peripheral blood reprogramming method episomal description age (30-34) Торговая марка EBiSC™ gender male growth mode adherent (pluripotent) application(s) cell culture | stem cell: suitable relevant disease(s) none shipped in dry ice storage temp. 196°C
Safety InformationRIDADR NONH for all modes of transport WGK Germany WGK 3 Flash Point F Not applicable Flash Point C Not applicable Узнать цену
Получите коммерческое предложение в течение 1 часа
Менеджер подготовит коммерческое предложение и позвонит, если понадобится уточнить детали вашего заказа
Анна Гловацкая
Менеджер по работе с клиентами
С 2010 года мы поставляем оборудование с заводов Европы. Берем на себя все — от подбора оборудования до внедрения на предприятии
Все сотрудники имеют высшее образование, закончили ведущие химические вузы страны, такие как РХТУ им Менделеева.
У большинства компаний срок ожидания составляет 10-12 недель.
Оборудование хранится на сухом отапливаемом складе, где поддерживается ровная температура.
Работаем с PonyExpress и Деловыми линиями. Вы также можете выбрать свою транспортную компанию или забрать товар со склада в Москве.
В случае любых неполадок за свой счет выполним ремонт в сервисном центре или на заводе-изготовителе. Или бесплатно заменим прибор на новый.
Производим пуско-наладку оборудования, валидацию, обучение сотрудников. Если нужно, привлекаем инженеров с заводов- изготовителей.
